col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


24 Results       Page 1

 [1] 
Elsevier: Vascular Pharmacology
  original article Date Title Authors   All Authors
1 [GO] 2024―Jan―23 COVID-19 plasma induces subcellular remodelling within the pulmonary microvascular endothelium Rainha Passi, Justyna Cholewa-Waclaw, Ryan Wereski, Matthew Bennett, Stefan Veizades, Bronwyn Berkeley, et al. (+8)
2 [GO] 2023―Dec―02 Sex differences in vascular endothelial function related to acute and long COVID-19 Kitselman A. Kayla, Jérôme Bédard-Matteau, Simon Rousseau, Reza Tabrizchi, Daneshtalab Noriko
3 [GO] 2022―Oct―14 Use of hiPSC-derived cardiomyocytes to rule out proarrhythmic effects of drugs: The case of hydroxychloroquine in COVID-19 Luca Sala, Vladislav Leonov, Manuela Mura, Alessandra Moretti, Lia Crotti, Massimiliano Gnecchi, Peter J. Schwartz
4 [GO] 2022―Oct―14 Doxorubicin-induced cardiotoxicity enhance SARS-CoV-2 infection susceptibility in human cardiomyocytes Edoardo Lazzarini, Azucena Rendon-Angel, Jessica Marcandalli Bassi, Alessandra Maria Lodrini, Vanessa Biemmi, Carolina Balbi, et al. (+7)
5 [GO] 2022―Jun―16 Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension Giovanna Manzi, Silvia Papa, Marco Valerio Mariani, Gianmarco Scoccia, Domenico Filomena, Claudia Malerba, et al. (+10)
6 [GO] 2022―May―18 Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles Jacopo Burrello, Elena Caporali, Lorenzo Grazioli Gauthier, Enea Pianezzi, Carolina Balbi, Elia Rigamonti, et al. (+15)
7 [GO] 2022―Mar―04 Endothelial dysfunction in acute and long standing COVID-19: A prospective cohort study Evangelos Oikonomou, Nektarios Souvaliotis, Stamatios Lampsas, Gerasimos Siasos, Garyphallia Poulakou, Panagiotis Theofilis, et al. (+12)
8 [GO] 2022―Jan―20 Interaction of ACEI antihypertensive agent's administration with the inflammatory status at admission concerning COVID-19 clinical stay outcomes Maria Martínez-Urbistondo, Víctor Moreno-Torres, Alberto Mora-Vargas, Esther Expósito-Palomo, Raquel Castejón-Díaz, Lidia Daimiel, et al. (+4)
9 [GO] 2021―Dec―03 Increased histone-DNA complexes and endothelial-dependent thrombin generation in severe COVID-19 Beth A. Bouchard, Christos Colovos, Michael A. Lawson, Zachary T. Osborn, Adrian M. Sackheim, Kara J. Mould, et al. (+4)
10 [GO] 2021―Nov―25 Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage Tiago J. Costa, Simone R. Potje, Thais F.C. Fraga-Silva, Júlio A. da Silva-Neto, Paula R. Barros, Daniel Rodrigues, et al. (+21)
11 [GO] 2021―Nov―10 Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients Mohammadarian Akbari, Mohammad Taheri, Golbarg Mehrpoor, Solat Eslami, Bashdar Mahmud Hussen, Soudeh Ghafouri-Fard, Noormohammad Arefian
12 [GO] 2021―Aug―05 Effect of ACE inhibitors and angiotensin receptor blockers on in-hospital mortality and length of stay in hospitalized COVID-19 patients Heather J. LaClair, Nadia Khosrodad, Anupam A. Sule, Tracy Koehler, Geetha Krishnamoorthy
13 [GO] 2021―Jul―23 The potential role of thymoquinone in preventing the cardiovascular complications of COVID-19 Ajaz Ahmad, Mohammad Raish, Khalid M. Alkharfy
14 [GO] 2021―Jun―05 Thromboprophylaxis strategies to improve the prognosis of COVID-19 Laurent Bertoletti, Behnood Bikdeli, Stéphane Zuily, Marc Blondon, Patrick Mismetti
15 [GO] 2021―Jun―02 Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis Vicky Mai, Boun Kim Tan, Sabine Mainbourg, François Potus, Michel Cucherat, Jean-Christophe Lega, Steeve Provencher
16 [GO] 2021―May―26 Crosstalk of TLR4, vascular NADPH oxidase, and COVID-19 in diabetes: What are the potential implications? Amanda Almeida de Oliveira, Kenia Pedrosa Nunes
17 [GO] 2021―Apr―22 COVID-19 and hypertension: Is there a role for dsRNA and activation of Toll-like receptor 3? Vanessa Dela Justina, Fernanda R. Giachini, Fernanda Priviero, R. Clinton Webb
18 [GO] 2021―Mar―19 A possible role for ST2 as prognostic biomarker for COVID-19 Rosetta Ragusa, Giuseppina Basta, Serena Del Turco, Chiara Caselli
19 [GO] 2021―Mar―19 In silico Nigellidine (N. sativa) bind to viral spike/active-sites of ACE1/2, AT1/2 to prevent COVID-19 induced vaso-tumult/vascular-damage/comorbidity Smarajit Maiti, Amrita Banerjee, Mehak Kanwar
20 [GO] 2021―Jan―14 A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications Cameron G. McCarthy, Stephanie Wilczynski, Camilla F. Wenceslau, R. Clinton Webb
21 [GO] 2021―Jan―12 Endothelial cells and SARS-CoV-2: An intimate relationship Lucas Cunha Barbosa, Thaynan Lopes, Luanna Prudencio de Araujo, Luciane Vieira de Oliveira Rosario, Valéria Pereira Ferrer
22 [GO] 2020―Nov―21 SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells Yuichiro J. Suzuki, Sofia I. Nikolaienko, Vyacheslav A. Dibrova, Yulia V. Dibrova, Volodymyr M. Vasylyk, Mykhailo Y. Novikov, et al. (+2)
23 [GO] 2020―Sep―28 RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies Augusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, Nausicaa Berselli, Lorenzo Blandi, Marialaura Bonaccio, et al. (+102)
24 [GO] 2020―May―11 Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection Soudeh Ghafouri-Fard, Rezvan Noroozi, Mir Davood Omrani, Wojciech Branicki, Ewelina Pośpiech, Arezou Sayad, et al. (+5)
 [1] 

24 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.014 sec